儿童重症腺病毒肺炎临床特征与危重症及死亡危险因素分析
该回顾性研究分析75例儿童重症腺病毒肺炎,发现腺病毒7型为主,鼻咽拭子核酸和mNGS检测阳性率高;5个肺叶受累是危重症独立危险因素,IL-6>100 ng/L是死亡独立危险因素;较大剂量利巴韦林联合综合治疗病死率15%。
要点
- 鼻咽拭子腺病毒核酸和血浆/肺泡灌洗液mNGS阳性率高,有助于早期诊断和分型。
- 5个肺叶受累是重症进展为危重症的独立危险因素(校正OR=49.641)。
- IL-6>100 ng/L是危重症患儿死亡的独立危险因素(校正OR=16.094)。
核心结论
- 腺病毒7型所致儿童重症腺病毒肺炎病死率为15%(11/75),危重症和死亡与年龄小、持续发热、广泛肺部病变及炎症因子显著升高相关。
研究设计与样本
- 回顾性分析华中科技大学同济医学院附属同济医院PICU 2019年1至10月收治的75例重症腺病毒肺炎患儿,分为重症组30例和危重症组45例。
主要发现
- 鼻咽拭子腺病毒抗原阳性率21%(15/72),血清IgM抗体阳性率13%(10/75),鼻咽拭子核酸阳性率75%(21/28)。
- 血浆和肺泡灌洗液mNGS阳性率分别为92%(33/36)和96%(54/56),95%(63/66)确定为腺病毒7型。
- 治愈率77%(58/75),好转率8%(6/75),病死率15%(11/75)。
- 危重症组利巴韦林治疗后发热>3 d比率51%(18/35),高于重症组的8%(2/26),χ²=12.949,P<0.05。
关键数值与推荐
- 危重症高危因素(均P<0.05):年龄<4岁、入PICU前发热时间、入PICU后发热时间、氧合指数<300 mmHg、铁蛋白>1 000 μg/L、LDH>1 500 U/L、5个肺叶受累、胸腔积液和(或)气漏。
- 5个肺叶受累为危重症独立危险因素:校正OR=49.641,95%CI 4.186~588.618,P=0.002。
- 死亡高危因素(均P<0.05):入PICU后发热时间、氧合指数<100 mmHg、铁蛋白>2 000 μg/L、IL-6>100 ng/L、LDH>1 500 U/L、胸腔积液和(或)气漏。
- IL-6>100 ng/L为危重症死亡独立危险因素:校正OR=16.094,95%CI 2.059~25.787,P=0.008。
临床怎么用
- 对4岁以下持续发热、肺部广泛病变及IL-6显著升高的重症腺病毒肺炎患儿应警惕危重症和不良预后。
- 采用鼻咽拭子腺病毒核酸和血浆或肺泡灌洗液mNGS有助于早期诊断,mNGS可用于腺病毒分型。
- 较大剂量利巴韦林联合呼吸支持、糖皮质激素、免疫球蛋白及器官功能维护等综合治疗有助于改善预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To analyze the clinical characteristics, risk factors for critical illness and death of severe adenovirus pneumonia in children, so as to provide clinical evidences for early diagnosis and reliable treatment. Methods: A total of 75 pediatric cases with severe adenovirus pneumonia admitted to Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology from January to October 2019 were studied. The clinical features, laboratory and imaging data, therapeutic approaches, efficacy of the treatments and prognosis were investigated retrospectively. Patients were divided into severe group and critical group. Chi square test and Mann-Whitney U rank sum test were used to analyze the data of the two groups. The risk factors for critical illness and death were analyzed by univariate and multivariate Logistic regression. Results: Among the 75 children, there were 52 males and 23 females, aged from 3 months to 8 years, including 30 of severe cases and 45 of critical case. The positive rate of adenovirus antigen in nasopharyngeal swab was 21% (15/72), and the positive rate of serum adenovirus IgM antibody was only 13% (10/75). However, the positive rate of adenovirus nucleic acid in nasopharyngeal swab was 75% (21/28). What is more, the positive rates of metagenomics next generation sequencing (mNGS) in plasma and bronchoalveolar lavage fluid were 92% (33/36) and 96% (54/56), respectively, of which 95% (63/66) were confirmed as adenovirus type 7. Relatively high dose of ribavirin and integrated therapeutic approaches (respiratory support, glucocorticoids, immunoglobulin and organ supportive therapies) were used. The recovery rate was 77% (58/75), the improvement rate was 8% (6/75) and the mortality rate was 15% (11/75). The proportion of children with the duration of fever longer than 3 days after ribavirin treatment in the critical group was significantly higher than that in the severe group(51% (18/35) vs. 8% (2/26), χ2=12.949, P<0.05). The risk factors for critical illness were younger than 4 years, longer duration of fever before and after admission to PICU, oxygenation index<300 mmHg (1 mm Hg=0.133 kPa), ferritin>1 000 μg/L, lactate dehydrogenase (LDH)>1 500 U/L, 5 lung lobes involvement, pleural effusion and (or) air leakage (all P<0.05). Among them, 5 lung lobes involvement was the independent risk factor for critical illness (adjusted OR=49.641, 95%CI 4.186-588.618, P=0.002). Risk factors for death included longer duration of fever after being admitted to PICU, oxygenation index<100 mmHg, ferritin>2 000 μg/L, interleukin (IL)-6>100 ng/L, LDH>1 500 U/L, pleural effusion and (or) air leakage (all P<0.05). Among them, IL-6>100 ng/L was the independent risk factor for the mortalities of critically ill children (adjusted OR=16.094, 95%CI 2.059-25.787, P=0.008). Conclusions: The mortality rate of severe pediatric adenovirus pneumonia caused by adenovirus type 7 is high. High positive rates of adenovirus nucleic acid in nasopharyngeal swabs and mNGS in plasma or bronchoalveolar lavage fluid contribute to early diagnosis, and mNGS can also be used for serotyping. Younger children under 4 years of age, persistent fever, extensive pulmonary lesions and significantly increased inflammatory cytokines such as IL-6 are warning indicators for critical illness and poor prognosis. Relatively high dose of ribavirin combined with integrated therapeutic approaches are beneficial for prognosis. 目的: 分析儿童重症腺病毒肺炎的临床特征、危重症及其死亡高危因素,为早期诊断及合理治疗提供临床依据。 方法: 回顾性分析华中科技大学同济医学院附属同济医院儿童重症医学科(PICU)2 019年1至10月收治的75例重症腺病毒肺炎患儿的临床资料和实验室检查资料,按照病情分析分为重症组和危重症组,采用χ²检验或Mann-Whitney秩和检验对比分析进行组间比较,危重症及其死亡的高危因素分析采用单因素和多因素Logistic回归分析。 结果: 75例重症腺病毒肺炎患儿中男52例、女23例,年龄为3月龄至8岁,重症组30例、危重症组45例。鼻咽拭子腺病毒抗原阳性率为21%(15/72),血清腺病毒IgM抗体阳性率为13%(10/75),鼻咽拭子腺病毒核酸阳性率为75%(21/28)。血浆和肺泡灌洗液的病原微生物宏基因组二代测序(mNGS)阳性率分别为92%(33/36)和96%(54/56),95%(63/66)确定为腺病毒7型。采用较大剂量利巴韦林和综合治疗措施(呼吸支持、糖皮质激素、免疫球蛋白及器官功能维护等),治愈率为77%(58/75),好转率8%(6/75),病死率为15%(11/75)。危重症组的利巴韦林治疗后发热>3 d比率明显高于重症组[51%(18/35)比8%(2/26),χ²=12.949,P<0.05]。重症病例发生危重症的高危因素包括年龄<4岁、入PICU前发热时间、入PICU后发热时间、氧合指数(P/F)<300 mmHg(1 mmHg=0.133 kPa)、铁蛋白>1 000 μg/L、乳酸脱氢酶(LDH)>1 500 U/L、5个肺叶受累、并发胸腔积液和(或)气漏(均P<0.05)。其中,5个肺叶受累为独立高危因素(校正OR=49.641,95%CI 4.186~588.618,P=0.002)。危重症病例的死亡高危因素包括入PICU后发热时间、P/F<100 mmHg、铁蛋白>2 000 μg/L、白细胞介素(IL)-6>100 ng/L、LDH>1 500 U/L、并发胸腔积液和(或)气漏(均P<0.05)。其中,IL-6>100 ng/L为独立高危因素(校正OR=16.094,95%CI 2.059~25.787,P=0.008)。 结论: 腺病毒7型所致儿童重症腺病毒肺炎的病死率较高;鼻咽拭子腺病毒核酸和血浆或肺泡灌洗液mNGS检出率高,有助于早期诊断,后者可用于分型;对于4岁以下儿童,持续发热、肺部广泛病变和IL-6水平明显增高者应高度警惕危重症和不良预后;早期较大剂量利巴韦林联合综合疗法有助于改善其预后。.
引用
- Huang H, Chen Y, Ma LY, et al. [Analysis of the clinical features and the risk factors of severe adenovirus pneumonia in children]. Zhonghua Er Ke Za Zhi. 2021. PMID: 33396998. doi:10.3760/cma.j.cn112140-20200704-00687
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。